GEVO Q1 2026 Earnings Significant EPS Miss Amid Operational Transition CRMT Q1 2026 Earnings WiderThanExpected Loss Weighs on Shares Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges KimberlyClark KMB Q1 2026 Earnings EPS Surpasses Estimates as Cost Discipline Lifts Profitability TRV Q1 2026 Earnings Strong EPS Beat Driven by Underwriting Strength FNLC Q1 2026 Earnings Modest Performance Amid Narrowing Margins